Results 11 to 20 of about 213,546 (300)

Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy [PDF]

Journal of Transplantation, 2013
Background. No studies have evaluated the impact of multiple generic immunosuppression medications on transplant coordinators (TCs) and patients. Methods.
A. S. Bruno, Bruno, A. S., Zagadailov, E. A., E. A. Zagadailov, Wiland, A. M., Parker, K., A. M. Wiland, NC DOCKS at East Carolina University, K. Parker   +8 more
core   +2 more sources

Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma. [PDF]

PLoS ONE, 2013
Immunosuppression therapy following liver transplantation often includes steroids. However, extended corticosteroid therapy is associated with numerous complications.
Zhenhai Yu, Lin Zhong, Huang Li, Zhihai Peng, Tonghai Xing, Li Huang, Yu Zhenhai, Zhong Lin, Xing Tonghai, Wang Shuyun, Shuyun Wang, Peng Zhihai   +11 more
core   +2 more sources

Gut microbiota modulation in cardiac cell therapy with immunosuppression in a nonhuman primate ischemia/reperfusion model

npj Regenerative Medicine
Gut microbiota affect transplantation outcomes; however, the influence of immunosuppression and cell therapy on the gut microbiota in cardiovascular care remains unexplored.
Emily F. Wissel, Hung-Chih Chen, Cindy M. C. Chang, Timothy A. Hacker, Marvin L. Hsieh, Theodore Steward, Patrick C. H. Hsieh, Yu-Che Cheng, Timothy J. Kamp, Po-Ju Lin, Jennifer Coonen   +10 more
core   +2 more sources

Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review. [PDF]

Front Oncol, 2021
Background and Aims: This study aimed at comparing the efficacy and safety of eltrombopag (EPAG) plus immunosuppressive therapies (ISTs) and haploidentical hematopoietic stem cell transplantation (haplo-HSCT) in the frontline treatment for severe ...
Yang Y, Ji J, Tang Z, Han B.
europepmc   +2 more sources

Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Long-term corticosteroid therapy is the standard of care for treatment of cardiac sarcoidosis (CS). The efficacy of long-term corticosteroid-sparing immunosuppression in CS is unknown.
Koth, Laura L, Vedantham, Vasanth, Zikherman, Julie, Benn, Bryan S, Parwani, Purvi, Hsia, Henry H, Gerstenfeld, Edward P, Klein, Liviu, Scheinman, Melvin M, Lee, Byron K, Murray, Tyler O, Pampaloni, Miguel H, Rosenthal, David G, De Marco, Teresa, Moss, Joshua D, Janmohamed, Munir, Selby, Van, Petek, Bradley J   +17 more
core   +3 more sources

Survival predictors in paraquat intoxification and role of immunosuppression

Toxicology Reports, 2014
Paraquat poisoning resulted in multiorgan failure and is associated with high mortality. We audited 83 historical cases of paraquat poisoning in past 2 years treated with conventional decontamination and supportive treatment, followed by enrolling 85 ...
Lee, Jun, Tem-Lom Fam, Koh, Keng-Hee, Chai, Alvin Jung-Mau, Clare Hui-Hong Tan, Lawrence Wei-Soon Hii, Hii, Lawrence Wei-Soon, Laura Lui-Sian Ngu, Mushahar, Lily, Fam, Tem-Lom, Lily Mushahar, Ngu, Laura Lui-Sian, Wan Shaariah Md Yusuf, Swee-Win Lam, Loh, Chek-Loong, Lam, Swee-Win, Tan, Clare Hui-Hong, Keng-Hee Koh, Yusuf, Wan Shaariah Md, Chek-Loong Loh, Alvin Jung-Mau Chai, Jun Lee   +21 more
core   +2 more sources

BK polyomavirus-associated nephropathy [PDF]

Childhood Kidney Diseases, 2022
BK polyomavirus (BKPyV) is a ubiquitous virus residing in the kidney tubules and is clinically significant only in immunocompromised patients. In clinical practice, BKPyV is a causative pathogen of BKPyV-associated nephropathy (BKVAN) in kidney allograft
Yo Han Ahn, Hee Gyung Kang
doaj   +1 more source

Dialysis Dependency at Discharge in De Novo ANCA Associated Renal Limited Vasculitis: Should We Avoid Further Immunosuppression?

Revista Portuguesa de Nefrologia e Hipertensão, 2022
Introduction: ANCA associated vasculitis commonly affects the kidneys. The intense inflammatory damage disrupts the glomerular architecture. Induction immunosuppressive therapy is responsible for a large part of the morbidity and mortality of these ...
Rui Filipe Nogueira, Nuno Afonso Oliveira, Margarida Gaudêncio, Ana Belmira, Rui Alves   +4 more
doaj   +1 more source

Autoimmune encephalitis and epilepsy: evolving definition and clinical spectrum [PDF]

Clinical and Experimental Pediatrics, 2020
Advances in autoimmune encephalitis studies in the past 10 years have led to the identification of new syndromes and biomarkers that have transformed the diagnostic approach to the disorder.
Joo Hee Seo, Yun-Jin Lee, Ki Hyeong Lee, Elakkat Gireesh, Holly Skinner, Michael Westerveld   +5 more
doaj   +1 more source

Impact of B Cell Depletion on COVID-19 in Kidney Transplant Recipients

Viruses, 2023
Kidney transplant recipients are patients at high risk for coronavirus disease 2019 (COVID-19) due to being on immunosuppressive therapy. B cell depletion therapy, including rituximab, is an important strategy for ABO-incompatible transplants.
Naohiro Aida, Taihei Ito, Kei Kurihara, Izumi Hiratsuka, Megumi Shibata, Atsushi Suzuki, Midori Hasegawa, Takashi Kenmochi   +7 more
doaj   +1 more source